ENCOMPASS LABORATORY LLC NPI 1871169706

NPI Information

  • NPI: 1871169706
  • Provider Name: ENCOMPASS LABORATORY LLC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • CLIA Number: 45D2224771
  • Address: 2323 S VOSS RD STE 455
    HOUSTON, TX
    ZIP 77057
  • Phone: (281) 501-5656

Map and Directions

Get Directions

NPI Details

ENCOMPASS LABORATORY LLC is a clinical medical laboratory in Houston, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. ENCOMPASS LABORATORY LLC NPI is 1871169706. The provider is registered as an organization entity type.

The provider's business location address is:

2323 S VOSS RD STE 455
HOUSTON, TX
ZIP 77057-863
Phone: (281) 501-5656

The provider's authorized official is Joe Wooten .
The authorized official title is Owner and has the following contact phone number (714) 396-1902.

The CLIA number assigned to this NPI record is 45D2224771 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Molecular pathology procedure level 1 (HCPCS:81400)
  • Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
  • Molecular pathology procedure level 5 (HCPCS:81404)
  • Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
  • Gene analysis (frataxin) of full sequence (HCPCS:81286)
  • Gene analysis (methyl cpg binding protein 2) full sequence analysis (HCPCS:81302)
  • Gene analysis (sphingomyelin phosphodiesterase 1, acid lysosomal) common variants (HCPCS:81330)
  • Gene analysis (serpin peptidase inhibitor, clade a, alpha-1 antiproteinase, antitrypsin, member 1) common variants (HCPCS:81332)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
  • Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
  • Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
  • Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
  • Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants (HCPCS:81291)
  • Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
  • Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
  • Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
  • Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
  • Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
  • Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
  • Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
  • Molecular pathology procedure level 2 (HCPCS:81401)
  • Molecular pathology procedure level 4 (HCPCS:81403)
  • Test for detecting genes associated with inherited disease of heart muscle (HCPCS:81439)
  • Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
  • Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
  • Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
  • Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
  • Detection test by nucleic acid for mycobacteria species (bacteria), amplified probe technique (HCPCS:87551)
  • Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique (HCPCS:87556)
  • Detection test by nucleic acid for mycobacteria avium-intracellulare (bacteria), amplified probe technique (HCPCS:87561)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
  • Detection test by nucleic acid for herpes virus-6, amplified probe technique (HCPCS:87532)
  • Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)

The enumeration date for this NPI number is 6/1/2021 and was last updated on 3/13/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical LaboratoryYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.